Core Insights - Park Ha (PHH) experienced a stock price increase of 2.94%, reaching $0.788 per share, with a total market capitalization of $20.77 million as of July 30 [1] - Financial data indicates that as of October 31, 2024, Park Ha's total revenue was 2.38 million RMB, reflecting a year-on-year decrease of 3.14%, while net profit attributable to the parent company was 478,600 RMB, down 43.83% year-on-year [1] Company Overview - Park Ha Biotechnology Co., Ltd. is a Cayman Islands-registered holding company primarily operated by its domestic entity, Jiangsu Park Ha Biotechnology Co., Ltd. [1] - The company's business focuses on developing its own skincare brand, direct sales of skincare products, and promoting franchise alliances [1] - The "Park Ha" brand, established in 2016, aims to provide solutions for problematic skin and opened its first store in 2017 [1] Franchise Operations - As of April 30, 2024, and October 31, 2023, the company had 43 and 38 franchisees in China, respectively, compared to 49 franchisees in 2022 [1] - Among these, 41, 36, and 45 franchisees operated under the "Park Ha" name in the respective years [1]